Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 1169-1174

  Yamashita, Keishi ^a   Mori, Masaki ^a   Shiraishi, Takeshi ^a   Shibuta, Kenji ^a,b   Sugimachi, Keizo ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRILYSIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LOCALIZATION; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

AGED; BLOTTING, NORTHERN; BLOTTING, WESTERN; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0034058083     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Sugimachi, K., Matsuoka, H., Ohno, S., Mori, M., and Kuwano, H. Multivariate approach for assessing the prognosis of clinical oesophageal carcinoma. Br. J. Surg., 75: 1115-1118, 1988.
2. Tsuda, T., Tahara, E., Kajiyama, G., Sakamoto, H., Terada, M., and Sugimura, T. High incidence of coamplification of hst-1 and int-2 genes in human esopnageal carcinomas. Cancer Res., 49: 5505-5508, 1989.
3. Naitoh, H., Shibata, J., Kawaguchi, A., Kodama, M., and Hattori, T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am. J. Pathol., 146: 1161-1169, 1995.
4. Nakamura, T., Necarda, H., Hoelscher, A. H., Bollschweiler, E , Harbeck, N., Becker, K., and Siewert, J. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus. Cancer (Phila.), 73: 1785-1794, 1994.
5. Kinugasa, S., Tachibana, S., Hishikawa, Y., Abe, S , Yoshimura, H., Monden, N., Dhar, D. K., and Nagasue, N. Prognostic significance of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the esophagus. Jpn. J. Clin. Oncol, 26: 405-410, 1996.
6. Kakegawa, T., and Yamana, H. Postoperative prognostic factors for carcinoma of the thoracic esophagus. Jpn. J. Cancer Chemother., 22: 573-579, 1995.
7. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., and Shalie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284: 67-68, 1980.
8. Matrisian, L. M. The matrix-degrading metalloproteinases. BioEssays, 14: 455-463, 1992.
9. Imai, K., Yokohama, Y., Nakanishi, I., Ohuchi, E., Fujii, Y., Noboru, N., and Okada, Y. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloprotemases and enzymatic properties. J. Biol. Chem , 270: 6691-6697, 1995.
10. Murphy, G., Cocket, M., Ward, R., and Docherty, A. J. P. Matrix metalloproteinase degradation of elastin, type IV collagen, and proteoglycan: a quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysin-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J., 277: 277-279, 1991.
11. Sires, U. I., Griffin, G. L., Broekelmann, T. J., Mecham, R. P., Murphy, G., Chung, A. E., Welgus, H. G., and Senior, R. M. Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. J. Biol. Chem., 268: 2069-2074, 1993.
12. Crabbe, T., Smith, B., O'Connell, J., and Docherty, A. Human progelatinase A can be activated by matrilysin. FEBS Lett., 345: 14-16, 1994.
13. Sang, Q. A., Bodden, M. K., and Windsor, L. J. Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin. J. Protein Chem., 15: 243-253, 1996.
14. Sires, U. I., Murphy, G., Baragi, V. M., Fliszar, C. J., Welgus, H. G., and Senior, R. M. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of α1-antitrypsin. Biochem. Biophys. Res. Commun., 204: 613-620, 1994.
15. Mori, M., Barnard, G. F., Mimori, K., Ueo, H., Akiyoshi, T., and Sugimachj, K. Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer (Phila.). 75: 1516-1519, 1995.
16. Honda, M., Mori, M., Ueo, H., Sugimachi, K., and Akiyoshi, T. Matrix metalloproteinase-7 expression in gastric carcinoma. Gut, 39: 444-448, 1996.
17. Mori, M., Staniunas, R. J., Barnard, G. F., Jessup, J. M., Steele, G. D., Jr., and Chen, L. B. The significance of carbohydrate expression in human colorectal cancer. Gastroenterology, 105: 820-826, 1993.
18. Mori, M., Barnard, G. F., Staniunas, R. J., Jessup, J. M., Steele, G. D., Jr., and Chen, L. B. Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer. Oncogene, 1993: 2821-2826, 1993.
19. Mimori, K., Mori, M., Inoue, H., Ueo, H., Mafune, K., Akiyoshi, T., and Sugimachi, K. Elongation factor 1γ mRNA expression in oesophageal carcinoma. Gut, 38: 66-70, 1996.
20. Ohta, S., Imai, K., Yamashita, K., Matsumoto, T., Azumano, I., and Okada, Y. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage Lab. Investig., 78: 79-87, 1998.
21. Yamashita, K., Azumano, I., Mai, M., and Okada, Y. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implication for vessel invasion and metastasis. Int. J. Cancer, 79: 187-194, 1998.
22. Shima, I., Sasaguri, Y., Kusukawa, J., Yamana, H., Fujita, H., Kakegawa, T., and Morimatsu, M. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer (Phila.), 70: 2747-2753, 1992.
23. Porte, H., Triboulet, J. P., Kotelevets, L., Carrat, F., Prevot, S., Nordlinger, B., DiGioia, Y., Wurtz, A., Comoglio, P., Gespach, C., and Chaste, E. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implication for prognosis. Clin. Cancer Res., 4: 1375-1382, 1998.
24. Adachi, Y., Itoh, F., Yamamoto, H., Arimura, Y., Kusano, M., Endoh, T., Hinoda, Y., Oohara, M., Hosokawa, M., and Imai, K. Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. Int. J. Oncol., 13: 1031-1035, 1998.
25. Witty, J. P., McDonnell, S., Newell, K., Cannon, P., Navre, M., Tressler, R., and Matrisian, L. M. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigeniciry in vivo. Cancer Res., 54: 4805-4812, 1994.
26. Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L. M., and Matrisian, L. M. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA. 94: 1402-1407, 1997.
27. Baragi, V. M., Fliszar, C. J., Conroy, M. C., Ye, Q-Z., Shipley, J. M., and Welgus, H. G. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin. J. Biol. Chem., 209: 12692-12697, 1994.
28. Kawano, N., Osawa, H., Ito, T., Nagashima, Y., Hirahara, F., Inayama, Y., Nakatani, Y., Kimura, S., Kitajima, H., Koshikawa, N., Miyazaki, K., and Kitamura, H. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. Hum. Pathol., 28: 613-622. 1997.
29. Bolon, I., Devouassoux, M., Robert, C., Moro, D., Bramhilla, C., and Brambilla, E. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas. Am. J. Pathol., 750: 1619-1629, 1997.
30. Borchers, A. H., Sanders, L. A., Powell, M. B., and Bowden, G. T. Melanocyte mediated paracrine induction of extracellular matrix degrading proteases in squamous cell carcinoma cells. Exp Cell Res., 231: 61-65, 1997.
31. Borchers, A. H., Powell, M. B., Fusenig, N. E., and Bowden, G. T. Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures. Exp. Cell Res., 213: 143-147, 1994.
32. Klein, R. D., Borchers, A. H., Sundareshan, P., Bougelet, C., Berkman, M. R., Nagle, R. B., and Bowden, G. T. Interleukin-1β secreted from monocytic cells induces the expression of matrilysin in the prostate cell line LNCaP. J. Biol. Chem., 272: 14188-14192, 1997.
33. Gaire, M., Magbanua, Z., McDonnell, S., McNeil, L., Lovett, D. H., and Matrisian, L. M. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J. Biol. Chem., 269: 2032-2040, 1994.
34. Burner, K. L., Rodgers, W. H., Gold, L. I., Korc, M., Hargrove, J. T., Matrisian, L. M., and Osteen, K G. Transforming growth factor β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl. Acad. Sci USA, 92: 7362-7366, 1995.
35. Momiyama, N., Koshikawa, N., and Shimada, H. Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro. Mol. Carcinog., 22: 57-63, 1998.
36. Powell, W. C., Knox, J. D., Navre, M., Grogan, T. M., Kittelson, J., Nagle, R. B., and Bowden, G. T. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res., 53: 417-422, 1993.
37. Itoh, F., Yamamoto, H., Hinoda, Y., and Imai, K. Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells. Cancer (Phila.), 77: 5717-1721, 1996.
38. Goseki, N., Koike, M., and Yoshida, M. Histologic characteristics of early stage esophageal carcinoma. Cancer (Phila.), 69: 1088-1093, 1992.
39. Yamamoto, H., Adachi, Y, Itoh, F, Iku, S., Matsuno, K., Kusano, M., Arimura, Y, Endo, T., Hinoda, Y., Hosokawa, M., and Imai, K. Association of matrilysin expression with recurrence and poor prognosis in human esophageal carcinoma. Cancer Res., 59: 3313-3316, 1999